论文信息 - Vedolizumab for Inflammatory Bowel Disease: Two‐Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study - 字舞流文

Vedolizumab for Inflammatory Bowel Disease: Two‐Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study

D. D. de Jong | C. J. van der Woude | F. Hoentjen | B. Oldenburg | M. Pierik | N. D. de Boer | N. Boer | R. West | J. Jansen | G. Dijkstra | A. van der Meulen-de Jong | A. Bodelier | A. D. de Vries | V. Biemans | M. Löwenberg | D. Jong | A. Vries | N. Srivastava | J. Haans | Andrea E. Meulen-de Jong | C. Woude | Andrea E. Meulen‐de Jong